as on October 16, 2025 at 8:40 pm IST
Day's Low
Day's High
1.06%
Downside
3.29%
Upside
52 Week's Low
52 Week's High
47.21%
Downside
2.96%
Upside
Check Ptc Therapeutics, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$5.4B
EPS (TTM)
8.0983
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
9.72
Industry PE ratio
8.355964912280701
PEG Ratio
0.81
EBITDA
894.9M
Revenue (TTM)
1.8B
Profit Margin
35.65%
Return On Equity TTM
-7740.12%
Track how Ptc Therapeutics, Inc. P/E has moved over time to understand its valuation trends.
Ptc Therapeutics, Inc. in the last 5 years
Lowest (-10.19x)
December 31, 2024
Industry (8.36x)
October 16, 2025
Today (9.72x)
October 16, 2025
Highest (7.09x)
March 31, 2025
Today’s Price to Earnings Ratio: 9.72x
Compare market cap, revenue, PE, and other key metrics of Ptc Therapeutics, Inc. with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
---|---|---|---|---|---|
BUY | $5.4B | 33.31% | 9.72 | 35.65% | |
BUY | $61.5B | 223.43% | -505.15 | -12.96% | |
NA | $37.1B | NA | NA | -3.89% | |
BUY | $105.7B | 87.04% | 28.99 | 31.86% | |
BUY | $59.6B | -3.89% | 14.07 | 31.37% |
The Ptc Therapeutics, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Ptc Therapeutics, Inc. investment value today
Current value as on today
₹1,87,944
Returns
₹87,944
(+87.94%)
Returns from Ptc Therapeutics, Inc. Stock
₹83,297 (+83.3%)
Dollar Returns*
₹4,647 (+4.65%)
Based on 20 analysts
50.00%
Buy
30.00%
Hold
20.00%
Sell
Based on 20 analysts, 50% of analysts recommend a 'BUY' rating for Ptc Therapeutics, Inc.. Average target price of $66.27
Get share price movements and forecasts by analysts on Ptc Therapeutics, Inc..
What analysts predicted
-1.51%DOWNSIDE
Target Price
$66.27
Current Price
$67.27
Analyzed by
20 Analysts
Target
$66.27
Ptc Therapeutics, Inc. target price $66.27, a slight downside of -1.51% compared to current price of $67.27. According to 20 analysts rating.
Search interest for Ptc Therapeutics, Inc. Stock has decreased by -53% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Best in 1 Year
In the last 1 year, PTCT has outperformed top 5 stocks with highest market-cap in its industry
Price Rise
In the last 1 year, PTCT stock has moved up by 86.7%
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 153.5% return, outperforming this stock by 120.8%
Revenue Fall
Revenue is down for the last 2 quarters, 1.17B → 178.87M (in $), with an average decrease of 84.8% per quarter
Profit Down
Netprofit is down for the last 2 quarters, 866.56M → -64.84M (in $), with an average decrease of 107.5% per quarter
Organisation | Ptc Therapeutics, Inc. |
Headquarters | 500 Warren Corporate Center Drive, Warren, NJ, United States, 07059 |
Industry | Health Technology |
CEO | Dr. Matthew B. Klein F.A.C.S., M.D., M.S. |
E-voting on shares | Click here to vote |
Name | Title |
---|---|
Mr. Mark Elliott Boulding J.D. | Executive VP & Chief Legal Officer |
Dr. Matthew B. Klein F.A.C.S., M.D., M.S. | CEO & Director |
Dr. Allan Steven Jacobson Ph.D. | Co-Founder & Independent Director |
Mr. Pierre Gravier M.S. | Chief Financial Officer |
Dr. Neil Almstead Ph.D. | Chief Technical Operations Officer |
Mr. Eric Pauwels | Chief Business Officer |
Ms. Linda Montella Carter | Senior VP & Chief Information Officer |
Dr. Lee Golden M.D., Ph.D. | Executive VP & Chief Medical Officer |
Ms. Christine Utter CPA | Senior VP, Chief Accounting Officer & Head of People Services |
Ms. Jane Baj | Vice President of Corporate Communications |
Ptc Therapeutics, Inc. share price today is $67.27 as on . Ptc Therapeutics, Inc. share today touched a day high of $69.48 and a low of $66.56.
Ptc Therapeutics, Inc. share touched a 52 week high of $69.26 on and a 52 week low of $35.51 on . Ptc Therapeutics, Inc. stock price today i.e. is trending at $67.27,which is 2.87% down from its 52 week high and 89.44% up from its 52 week low.
Ptc Therapeutics, Inc. market capitalisation is $0.01T as on .
Indian investors can start investing in Ptc Therapeutics, Inc. (PTCT) shares with as little as ₹87.83 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹878.30 in Ptc Therapeutics, Inc. stock (as per the Rupee-Dollar exchange rate as on ).
Based on Ptc Therapeutics, Inc. share’s latest price of $67.27 as on October 16, 2025 at 8:40 pm IST, you will get 0.1487 shares of Ptc Therapeutics, Inc.. Learn more about
fractional shares .
Ptc Therapeutics, Inc. stock has given 33.31% share price returns and 21.02% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?